Anna Doleschall

ORCID: 0000-0003-0983-1380
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Long-Term Effects of COVID-19
  • RNA and protein synthesis mechanisms
  • Erythropoietin and Anemia Treatment
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Complement system in diseases
  • SARS-CoV-2 and COVID-19 Research
  • Advanced Biosensing Techniques and Applications
  • COVID-19 Clinical Research Studies
  • Advanced biosensing and bioanalysis techniques

RWTH Aachen University
2023

Semmelweis University
2017

Abstract Purpose Prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been observed in immunocompromised hosts. Early monotherapy with direct-acting antivirals or monoclonal antibodies, as recommended the international guidelines, does not prevent this certainty. Dual therapies might therefore act synergistically. Methods This retrospective, multicentre study compared treatment strategies for corona virus disease-19 (COVID-19) combinations...

10.21203/rs.3.rs-3259912/v1 preprint EN cc-by Research Square (Research Square) 2023-08-18

We demonstrate the first application of a nuclease resistant aptamer, so-called Spiegelmer, in sandwich-type affinity assay by quantitative assessment cardiac Troponin I (cTnI) blood serum samples.

10.1039/c7ay01777d article EN cc-by-nc Analytical Methods 2017-01-01
Coming Soon ...